BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34312842)

  • 1. Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination.
    Sassi M; Khefacha L; Merzigui R; Rakez R; Boukhriss S; Laatiri MA
    Br J Haematol; 2021 Dec; 195(5):649. PubMed ID: 34312842
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 3. Cold agglutinin disease after COVID-19 vaccine.
    Aoun SA; Motabi I
    Br J Haematol; 2021 Dec; 195(5):650. PubMed ID: 34176130
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophagocytic lymphohistiocytosis after COVID-19 vaccination.
    Tang LV; Hu Y
    J Hematol Oncol; 2021 Jun; 14(1):87. PubMed ID: 34088334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years.
    King H; Deshpande S; Woodbridge T; Hilliard T; Standing J; Lewis M; Ward L; Finn A; Roderick M
    Arch Dis Child; 2022 Feb; 107(2):205-207. PubMed ID: 34446440
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
    Ruhe J; Schnetzke U; Kentouche K; Prims F; Baier M; Herfurth K; Schlosser M; Busch M; Hochhaus A; Wolf G
    Ann Hematol; 2022 Mar; 101(3):717-719. PubMed ID: 34309715
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent Skin Rash, Epigastralgia, and Arthralgia After SARS-CoV-2 mRNA Immunization and Breakthrough Infection.
    Katsube K; Nagai T; Watanabe T
    Gastroenterology; 2024 Jul; 167(2):e5-e8. PubMed ID: 38199589
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination.
    Ai S; Awford A; Roncolato F
    J Med Virol; 2022 Jan; 94(1):14-16. PubMed ID: 34406660
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.
    Sprute R; Hieber ML; Jachimowicz RD
    Infection; 2022 Dec; 50(6):1617-1618. PubMed ID: 35389184
    [No Abstract]   [Full Text] [Related]  

  • 11. Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.
    Fox TA; Kirkwood AA; Enfield L; O'Reilly M; Arulogun S; D'Sa S; O'Nions J; Kavi J; Vitsaras E; Townsend W; Burns SO; Gohil SH; Cwynarski K; Thomson KJ; Noursadeghi M; Heyderman RS; Rampling T; Ardeshna KM; McCoy LE; Morris EC
    Br J Haematol; 2021 Dec; 195(5):706-709. PubMed ID: 34545952
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 mRNA vaccine (Comirnaty)-induced myocarditis.
    Wong J; Sharma S; Yao JV; Aggarwal A; Grigg L
    Med J Aust; 2022 Feb; 216(3):122-123. PubMed ID: 35075640
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.
    Med Lett Drugs Ther; 2022 Jan; 64(1642):16. PubMed ID: 35134045
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.
    Wang Y
    EBioMedicine; 2021 Nov; 73():103677. PubMed ID: 34742128
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2.
    Swoboda J; Wittschieber D; Sanft J; Kleemann S; Elschner S; Ihle H; Hubig M; Pletz MW; Mall G; Gassler N
    Histopathology; 2021 Apr; 78(5):727-737. PubMed ID: 33067892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 18. mRNA COVID-19 Vaccine-Related Anaphylactoid Reaction and Coronary Thrombosis.
    Hinton J; Briosa E Gala A; Corbett S
    Mayo Clin Proc; 2021 Dec; 96(12):3182-3183. PubMed ID: 34863404
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?
    D'Angelo T; Cattafi A; Carerj ML; Booz C; Ascenti G; Cicero G; Blandino A; Mazziotti S
    Can J Cardiol; 2021 Oct; 37(10):1665-1667. PubMed ID: 34118375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination.
    Park HW; Min GJ; Kim TY; Cho SG
    Acta Haematol; 2023; 146(1):65-71. PubMed ID: 36096118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.